$3.55 Billion is the total value of Third Security, LLC's 23 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XON | Buy | INTREXON CORP | $2,800,449,000 | +66.3% | 61,724,682 | +0.9% | 78.80% | +2.5% |
| HALO | HALOZYME THERAPEUTICS INC | $282,975,000 | +48.0% | 19,816,162 | 0.0% | 7.96% | -8.8% | |
| ZIOP | Buy | ZIOPHARM ONCOLOGY INC | $207,564,000 | +129.6% | 19,272,415 | +8.1% | 5.84% | +41.5% |
| FCSC | FIBROCELL SCIENCE INC | $70,556,000 | +74.1% | 15,644,427 | 0.0% | 1.98% | +7.4% | |
| EPD | Buy | ENTERPRISE PRODS PARTNERS L | $34,110,000 | +2.4% | 1,035,834 | +12.3% | 0.96% | -36.8% |
| SYN | SYNTHETIC BIOLOGICS INC | $26,939,000 | +50.0% | 12,300,768 | 0.0% | 0.76% | -7.6% | |
| HSGX | HISTOGENICS CORP | $26,879,000 | -9.2% | 2,690,570 | 0.0% | 0.76% | -44.0% | |
| ET | ENERGY TRANSFER EQUITY L P | $23,836,000 | +10.4% | 376,200 | 0.0% | 0.67% | -31.9% | |
| PAA | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $19,508,000 | -5.0% | 400,000 | 0.0% | 0.55% | -41.4% | |
| OVAS | OVASCIENCE INC | $12,962,000 | -21.5% | 373,224 | 0.0% | 0.36% | -51.5% | |
| GEL | GENESIS ENERGY L Punit ltd partn | $10,199,000 | +10.8% | 217,000 | 0.0% | 0.29% | -31.7% | |
| OGEN | ORAGENICS INC | $10,036,000 | +14.6% | 9,839,221 | 0.0% | 0.28% | -29.5% | |
| NS | NUSTAR ENERGY LP | $7,072,000 | +5.1% | 116,500 | 0.0% | 0.20% | -35.2% | |
| TCP | TC PIPELINES LP | $6,320,000 | -8.5% | 97,000 | 0.0% | 0.18% | -43.5% | |
| MMLP | MARTIN MIDSTREAM PRTNRS L Punit l p int | $5,025,000 | +31.8% | 141,800 | 0.0% | 0.14% | -19.0% | |
| RGP | Buy | REGENCY ENERGY PARTNERS L P | $4,305,000 | +1.9% | 188,250 | +7.0% | 0.12% | -37.3% |
| CMLP | CRESTWOOD MIDSTREAM PARTNERSunit ltd partner | $4,130,000 | -4.4% | 284,620 | 0.0% | 0.12% | -41.1% | |
| TBIO | TRANSGENOMIC INC | $1,110,000 | -28.3% | 770,490 | 0.0% | 0.03% | -56.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-04-24
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HALOZYME THERAPEUTICS INC | 36 | Q1 2022 | 37.6% |
| TC PIPELINES LP | 30 | Q3 2020 | 1.1% |
| ENTERPRISE PRODS PARTNERS L | 29 | Q2 2020 | 6.7% |
| ENERGY TRANSFER LP | 29 | Q2 2020 | 2.7% |
| NUSTAR ENERGY LP | 29 | Q2 2020 | 1.3% |
| INTREXON CORP | 26 | Q4 2019 | 82.5% |
| ZIOPHARM ONCOLOGY INC | 25 | Q2 2020 | 7.5% |
| AQUABOUNTY TECHNOLOGIES INC | 23 | Q3 2022 | 16.9% |
| SYNTHETIC BIOLOGICS INC | 21 | Q2 2018 | 4.0% |
| ORAGENICS INC | 19 | Q4 2017 | 3.9% |
View Third Security, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2022-11-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Third Security, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.